July 24, 2017. Comments to the U.S. EPA on the Proposed Interim Decisions for Aldicarb, Azoxystrobin, Bifenazate, Chlorpyrifos-methyl, Ethalfluralin, and Pirimiphos-methyl
Read the comments.